Bio-gene Technology Share Price and Company Fundamentals
Last traded: Yesterday at 11:42 PM
Bio-Gene Technology Limited, an agtech development company, engages in the development and commercialization of naturally derived insecticide products in Australia and internationally. Its products include Flavocide, a synthetically produced nature-identical compound; and Qcide, a natural plant-derived oil with high levels of tasmanone. The company has a research collaboration agreement with James Cook University for experiments demonstrating the value of pre-conditioning biomass prior to distillation; Cesar for assessing the insecticidal activity of its molecules against a range of insect species; Advanced Molecular Technologies; CSIRO for a chemistry development process; the Department of Agriculture and Fisheries, Queensland Government for assessing activity against grain storage pests; Eurofins; Grain Research Development Corporation; Pacific Discovery Services; Purdue University; Southern Cross University for chemical analysis of natural products; University of Florida; and University of Technology. It serves animal health, crop protection, grain storage, public health, and consumer applications, as well as insect management in crop protection. The company was incorporated in 1995 and is based in Melbourne, Australia.
Key Metrics
PE ratio
-
PB ratio
5.17
Dividend yield
-
Beta
0.85
Market cap
$9.46M
Enterprise value
$8.32M
Company profile
| Industry / Sector | Biotechnology / Healthcare |
|---|---|
| Website | https://www.bio-gene.com.au |
| Mailing address | 400 Collins Street Level 6 Melbourne VIC 3000 Australia |
| Phone / Fax | 61 3 9068 1062 / |
Dividends
More: Bio-gene Technology Dividend history, yield and payout ratio
Dividend yield
-
Dividend amount
$-
Payout ratio
0.00%
5Y Avg. yield
-%
Bio-gene Technology paid $- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.BGT dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Bio-gene Technology.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Timothy Owen Grogan B.Sc., LLB | MD, CEO & Director | ||
| Mr. Edmond Tern B.A., CPA | CFO & Company Secretary | ||
| Mr. Peter Donald May AFA1M, AFAIM, GAICD, M.B.A. | Executive Director of Research & Development and Executive Director |
Profitability and management effectiveness
Profit margin
0.00%
Operating margin
-213.42%
Return on assets
-61.77%
Return on equity
-116.99%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Bio-gene Technology is 9.46M and its enterprise value is 8.32M. The enterprise value to revenue ratio of BGT is 15.86. The enterprise value to EBITDA ratio of BGT is -3.22.
The BGT's stocks Beta value is 0.85 making it 15% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Bio-gene Technology (BGT)
- Adbri (ABC)
- Amcor Plc (AMC)
- Alumina (AWC)
- Bhp Group (BHP)
- Brickworks (BKW)
- Boral (BLD)
- Bluescope Steel (BSL)
- CSR (CSR)
- Evolution Mining (EVN)
- Fletcher Building (FBU)
- Fortescue Metals Group (FMG)
- Gold Road Resources (GOR)
- IGO (IGO)
- Iluka Resources (ILU)
- Incitec Pivot (IPL)
- James Hardie Industries Plc (JHX)
- Lynas Rare Earths (LYC)
- Mineral Resources (MIN)
- Newcrest Mining (NCM)
- Northern Star Resources (NST)
- Nufarm (NUF)
- Orora (ORA)
- Orica (ORI)
- Oz Minerals (OZL)
- Pilbara Minerals (PLS)
- Perenti Global (PRN)
- Rio Tinto (RIO)
- Regis Resources (RRL)
- Resolute Mining (RSG)
- South32 (S32)
- St Barbara (SBM)
- Sandfire Resources (SFR)
- Sims (SGM)
- Silver Lake Resources (SLR)
- Western Areas (WSA)
Bio-gene Technology (ASX:BGT) Frequently Asked Questions
1. What is Bio-gene Technology's Stock Symbol?
Bio-gene Technology trades on ASX under the ticker symbol "BGT".
2. What is Bio-gene Technology's stock price today?
One share of BGT stock can currently be purchased for approximately $0.031.
3. How can I contact Bio-gene Technology?
Bio-gene Technology's mailing address is 400 Collins Street Level 6 Melbourne VIC 3000 Australia. The company can be reached via phone at 61 3 9068 1062.
4. What is Bio-gene Technology's official website?
The official website of Bio-gene Technology is https://www.bio-gene.com.au.